Final height in a patient with Laron syndrome after long-term therapy with rhlGF-I and short-term therapy with LHRH-analogue and oxandrolone during puberty. | J Endocrinol Invest;28(3): 274-9, 2005 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Final height in a patient with Laron syndrome after long-term therapy with rhlGF-I and short-term therapy with LHRH-analogue and oxandrolone during puberty.

Zucchini, S; Scarano, E; Baldazzi, L; Mazzanti, L; Pirazzoli, P; Cacciari, E.

Affiliation

Zucchini S; Department of Pediatrics, S. Orsola-Malpighi Hospital, University of Bologna, Italy.

J Endocrinol Invest ; 28(3): 274-9, 2005 Mar.

Article in En | MEDLINE | ID: mdl-15952414

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Oxandrolone / Body Height / Insulin-Like Growth Factor I / Gonadotropin-Releasing Hormone / Laron Syndrome / Anabolic Agents Limits: Child / Female / Humans Language: En Journal: J Endocrinol Invest Year: 2005 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Oxandrolone / Body Height / Insulin-Like Growth Factor I / Gonadotropin-Releasing Hormone / Laron Syndrome / Anabolic Agents Limits: Child / Female / Humans Language: En Journal: J Endocrinol Invest Year: 2005 Document type: Article Affiliation country: Country of publication: